Nonalcoholic steatohepatitis: risk factors for liver fibrosis

被引:66
|
作者
Shimada, M [1 ]
Hashimoto, E [1 ]
Kaneda, H [1 ]
Noguchi, S [1 ]
Hayashi, N [1 ]
机构
[1] Tokyo Womens Med Coll, Inst Gastroenterol, Tokyo, Japan
关键词
nonalcoholic steatohepatitis; liver fibrosis; liver cirrhosis; steatohepatitis; Mallory body;
D O I
10.1016/S1386-6346(02)00246-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of this study was to clarify the clinicopathological features of nonalcoholic steatohepatitis (NASH) and identify risk factors for severe hepatic fibrosis. Materials and Methods: Eighty-one patients with biopsy-proven NASH were studied. In all patients, the diagnosis of NASH was established on the basis of following criteria: (1) the presence of steatosis, lobular inflammation, and ballooning degeneration on liver biopsy, (2) intake of less than 20 g of ethanol per week, and (3) appropriate exclusion of other liver diseases. Results: The median age was 54 years (range: 21-82 years) and 41 patients were women (51%). Obesity was present in 58 patients (72%), while 25 patients (31%) had diabetes mellitus and 33 patients (41%) had hyperlipidemia. Histologically, 58 patients (72%) had trivial to moderate fibrosis, 6 patients (7%) had bridging fibrosis, and 17 patients (21%) had established cirrhosis. Multiple logistic regression analysis assessed clinical, laboratory and histological factors showed that the risk factors for fibrosis were a low platelet count (P = 0.0016), a high AST/ALT ratio (P = 0.0229), and the presence of Mallory bodies (P = 0.0209). To exclude factors that were a consequence of liver cirrhosis, variables included in the multiple logistic analysis were age, gender, diabetes, obesity, and hyperlipidemia. This showed that older age (P=0.0037) and the absence of hyperlipidemia (P = 0.0150) were risk factors for fibrosis. Conclusions: We found that a low platelet count, a high AST/ALT ratio, and the presence of Mallory bodies were significant predictors of severe liver fibrosis. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 50 条
  • [41] Prothrombotic Factors in Histologically Proven Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Verrijken, An
    Francque, Sven
    Mertens, Ilse
    Prawitt, Janne
    Caron, Sandrine
    Hubens, Guy
    Van Marck, Eric
    Staels, Bart
    Michielsen, Peter
    Van Gaal, Luc
    HEPATOLOGY, 2014, 59 (01) : 121 - 129
  • [42] Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis
    Huang, He-ming
    Fan, Shi-jie
    Zhou, Xiao-ru
    Liu, Yan-jun
    Li, Xiao
    Liao, Li-ping
    Huang, Jing
    Shi, Cui-cui
    Yu, Liang
    Fu, Rong
    Fan, Jian-gao
    Zhang, Yuan-yuan
    Luo, Cheng
    Li, Guang-ming
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (04) : 941 - 953
  • [43] Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
    hashizume, Hiroaki
    Sato, Ken
    Ichikawa, Takeshi
    Kakizaki, Satoru
    Takagi, Hitoshi
    Mori, Masatomo
    GASTROENTEROLOGY, 2009, 136 (05) : A847 - A847
  • [44] Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis
    Iacobellis, Angelo
    Marcellini, Matilde
    Andriulli, Angelo
    Perri, Francesco
    Leandro, Gioacchino
    Devito, Rita
    Nobili, Valerio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (48) : 7821 - 7825
  • [45] Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
    Caussy, Cyrielle
    Chuang, Jen-Chieh
    Billin, Andrew
    Hu, Tao
    Wang, Ya
    Subramanian, G. Mani
    Djedjos, C. Stephen
    Myers, Robert P.
    Dennis, Edward A.
    Loomba, Rohit
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [46] Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis A Meta-analysis
    Musso, Giovanni
    Cassader, Maurizio
    Paschetta, Elena
    Gambino, Roberto
    JAMA INTERNAL MEDICINE, 2017, 177 (05) : 633 - 640
  • [47] RISK FACTORS FOR DEVELOPING DIASTOLIC DYSFUNCTION IN NONALCOHOLIC STEATOHEPATITIS
    Jadhav, S. N.
    Radchenko, V. G.
    Seliverstov, P. V.
    Sitkin, S. I.
    ARCHIV EUROMEDICA, 2019, 9 (01): : 104 - 105
  • [48] Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis
    Kozlitina, Julia
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2020, 49 (01) : 25 - +
  • [49] Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation
    Sourianarayanane, Achuthan
    Arikapudi, Sowminya
    McCullough, Arthur J.
    Humar, Abhinav
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (04) : 481 - 487
  • [50] THROMBOSPONDIN-2 AS A BIOMARKER FOR NONALCOHOLIC STEATOHEPATITIS AND ADVANCED LIVER FIBROSIS
    Kozumi, Kazuhiro
    Kodama, Takahiro
    Yamada, Ryoko
    Hikita, Hayato
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2021, 74 : 50A - 50A